PRPO
Precipio IncNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$40.77M
P/E Ratio
—
EPS
$-0.45
Beta
1.38
52W High
$33.63
52W Low
$10.50
50-Day MA
$26.77
200-Day MA
$23.43
Dividend Yield
—
Profit Margin
-3.57%
Forward P/E
15.43
PEG Ratio
0.00
About Precipio Inc
Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. The company is headquartered in New Haven, Connecticut.
Fundamentals
| Revenue (TTM) | $25.83M |
| Gross Profit (TTM) | $11.29M |
| EBITDA | -356,000 |
| Operating Margin | -21.30% |
| Return on Equity | -7.13% |
| Return on Assets | -5.74% |
| Revenue/Share (TTM) | $15.42 |
| Book Value | $8.18 |
| Price-to-Book | 2.85 |
| Price-to-Sales (TTM) | 1.58 |
| EV/Revenue | 1.6 |
| EV/EBITDA | 44.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 36.20% |
| Shares Outstanding | $1.79M |
| Float | $1.43M |
| % Insiders | 11.80% |
| % Institutions | 17.60% |
Historical Volatility
HV 10-Day
46.56%
HV 20-Day
48.95%
HV 30-Day
55.46%
HV 60-Day
62.73%
HV Rank
11.5%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 6/13/2026